Yasukawa K, Saito S, Kubo T, et al. Low-dose recombinant canine interferon-gamma for treatment of canine atopic dermatitis：an open randomized comparative trial of two doses[J]. Vet Dermatol, 2010, 21(1)：42-49.
[3]
Himmler A, Hauptmann R, Adolf GR, et al. Structure and expression in Escherichia coli of canine interferon-alpha genes[J]. J Interferon Res, 1987, 7(2)：173-183.
[4]
Zhao N, Yao H, Lan L, et al. Efficient production of canine interferon-alpha in silkworm Bombyx mori by use of a BmNPV/Bac-to-Bac exp-ression system[J]. Appl Microbiol Biotechnol, 2008, 78(2)：221-226.
Usami A, Suzuki T, Nagaya H, et al. Silkworm as a host of baculo-virus expression[J]. Curr Pharm Biotechnol, 2010, 11(3)：246-250.
[9]
Zhou J, Liu W, Peng S, et al. Papillomavirus capsid protein expres-sion level depends on the match between codon usage and tRNA availability[J]. J Virol, 1999, 73(6)：4972-4982.
[10]
Isaacs A, Lindenmann J. Virus interference. I. The interferon[J]. Proc R Soc Lond B Biol Sci, 1957, 147(927)：258-267.
[11]
Nishikawa Y, Iwata A, Nagasawa H, et al. Comparison of the growth inhibitory effects of canine IFN-alpha,-beta and-gamma on canine cells infected with Neospora caninum tachyzoites[J]. J Vet Med Sci, 2001, 63(4)：445-448.
[12]
Devos K, Duerinck F, Van Audenhove K, et al. Cloning and expres-sion of the canine interferon-gamma gene[J]. J Interferon Res, 1992, 12(2)：95-102.
[13]
Taira O, Watanugi I, Hagiwara Y, et al. Cloning and expression of canine interferon-alpha genes in Escherichia coli. [J]. J Vet Med Sci, 2005, 67(10)：1059-1062.
Litzlbauer P, Weber K, Mueller RS. Oral and subcutaneous therapy of canine atopic dermatitis with recombinant feline interferon omega[J]. Cytokine, 2014, 66(1)：54-59.
[16]
Li Z, Yi Y, Yin X, et al. Expression of foot-and-mouth disease virus capsid proteins in silkworm-baculovirus expression system and its utilization as a subunit vaccine[J]. PLoS One, 2008, 3(5)：e2273.
